Log In
Print
BCIQ
Print
Print this Print this
 

NLG919

  Manage Alerts
Collapse Summary General Information
Company NewLink Genetics Corp.
DescriptionOral small molecule indoleamine 2,3-dioxygenase (INDO; IDO) pathway inhibitor
Molecular Target Indoleamine 2,3-dioxygenase (INDO) (IDO)
Mechanism of ActionIndoleamine 2,3-dioxygenase (INDO) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today